News

According to findings presented at the 2017 ASCO Annual Meeting, patients with low-risk advanced colon cancer would benefit from a reduction in chemotherapy post-surgery, without increasing risk of recurrence, to reduce risk of neuropathy.

According to findings reported at ASCO 2017, patients receiving treatment for metastatic cancer who used a web-based tool to report their symptoms lived on average 5 months longer.

According to findings presented at 2017 ASCO, frontline treatment with ribociclib (Kisqali) plus letrozole improved PFS for patients with HR+/HER2- advanced breast cancer.

As presented at ASCO 2017, a recent study found that psychological intervention can substantially lower the fear of cancer recurrence in survivors.

A recent survey found that women with ovarian cancer are uncertain of what to expect, and experience a gap when communicating with healthcare providers.

The Bladder Cancer Advocacy Network (BCAN) announced the recipients of the 2017 Young Investigator Awards.

The traditional Chinese exercise, tai chi, may assist breast cancer survivors experiencing insomnia.

A recent study found that gliomas are less common among patients with higher blood sugar and diabetes.

A form of T-cell (non-Hodgkin) lymphoma known as breast implant associated anaplastic large-cell lymphoma (BIA-ALCL) has been noted as a rare association with the implant-based approach of reconstructive surgery post mastectomy.

The Environmental Working Group has issued published its 11th annual guide including information on beach and sport sunscreens, moisturizers and lip products containing Sun Protection Factor (SPF).

The FDA has granted approval to the second generation ALK-inhibitor, ceritinib for treatment of patients with ALK-positive, metastatic non-small cell lung cancer (NSCLC).

A recent study provides more evidence toward the link between electronic cigarette use and bladder cancer risk.

IBM Watson Health, Cota and Hackensack Meridian Health have joined together to help oncologists make evidence- and outcomes-based clinical decisions for their cancer patients, which could reduce total cost of care.

Pembrolizumab (Keytruda) has been granted accelerated approval for certain solid tumors.

Members of the ACCC have created an online course, Financial Advocacy Boot Camp, to help financial navigators find the funds for their patients.

Overall survival for patient with cutaneous melanoma was significantly lower for non-white patients, indicating a need for more emphasis on screening and awareness in these populations.

More Stage I cancers were diagnosed after the passage of the Affordable Care Act (ACA), also known as Obamacare, within five screenable disease types: colorectal cancer, female breast cancer, cervical cancer, lung cancer, and prostate cancer).

The FDA has granted approval to pembrolizumab (Keytruda) for the treatment of patients with locally advanced or metastatic urothelial carcinoma.

The human papillomavirus (HPV) vaccine has reduced the prevalence of high-risk oral HPV infections by 88& in young adults that have had at least 1 dose of the vaccine.

Eating tree nuts may improve overall survival and reduce the risk of recurrence in patients with colon cancer.

A recent analysis showed that many women within the recommended age for routine screening are not up to date on Pap tests.

A recent study has found that, when it comes to physical activity recommendations, there is a disparity between what patients want and what their providers do.

Researchers found that tai chi chih, including guided movement and meditation, may be helpful in reducing insomnia experienced by breast cancer survivors.

For asymptomatic adults, the US Preventive Services Task Force (USPSTF) recommends against screening for thyroid cancer.

The FDA has granted an accelerated approval to pembrolizumab (Keytruda) for use in combination with pemetrexed plus carboplatin as a frontline treatment for patients with non-small cell lung cancer (NSCLC).

Expert Oncology Nurses to Lead Inaugural Conference.

The FDA has approved the co-packaging of oral medication ribociclib and letrozole, used to treat HR-positive, HER2-negative advanced breast cancer in postmenopausal women.

The FDA has granted accelerated approval to avelumab (Bavencio) for the treatment of patients with locally advanced or metastatic urothelial carcinoma.

At the 2017 ONS Annual Congress, nurses from John Hopkins Sidney Kimmel Cancer Center reported on their study involving vincristine infused via minibag infusions.